RecruitingNCT06805409
VExUS in Ards Patients and Association with AKI
Evaluation of Venous Congestion Using Doppler and Venous Excess Ultrasound Score (VExUS) During Acute Respiratory Distress Syndrome and Its Association with Acute Kidney Injury
Sponsor
Assistance Publique - Hôpitaux de Paris
Enrollment
120 participants
Start Date
Dec 2, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
A single-center prospective observational study will be conducted with the aim of determining the prevalence of venous congestion during ARDS using venous Doppler and the VExUS score.
Eligibility
Min Age: 18 YearsMax Age: 100 Years
Inclusion Criteria4
- Patients ≥18 years old
- Moderate to severe ARDS according to the Berlin definition
- Requiring catecholamine support
- Undergoing invasive mechanical ventilation for less than 48 hours
Exclusion Criteria9
- Patients presenting with acute kidney injury KDIGO III requiring renal replacement therapy before the initial ultrasound evaluation
- Requirement for veno-venous or veno-arterial ECMO circulatory support before inclusion
- Patients with end-stage chronic kidney disease, on dialysis, and/or kidney transplant recipients
- History of Child C cirrhosis and/or liver transplantation and/or portal hypertension
- History of portal thrombosis
- Known history of pulmonary hypertension
- Pregnant women
- Patients under legal protection
- Patients who have expressed opposition to participating in the research
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06805409